The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
出版年份 2018 全文链接
标题
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
作者
关键词
-
出版物
EUROPEAN HEART JOURNAL
Volume 39, Issue 16, Pages 1330-1393
出版商
Oxford University Press (OUP)
发表日期
2018-03-02
DOI
10.1093/eurheartj/ehy136
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST-AF PCI trial
- (2018) Pascal Vranckx et al. AMERICAN HEART JOURNAL
- Safety of Uninterrupted Periprocedural Edoxaban Versus Phenprocoumon for Patients Who Underwent Left Atrial Catheter Ablation Procedures
- (2018) Marc Kottmaier et al. AMERICAN JOURNAL OF CARDIOLOGY
- Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial
- (2018) Meena P. Rao et al. AMERICAN JOURNAL OF MEDICINE
- Comparing Bleeding Risk Assessment Focused on Modifiable Risk Factors Only Versus Validated Bleeding Risk Scores in Atrial Fibrillation
- (2018) Yutao Guo et al. AMERICAN JOURNAL OF MEDICINE
- Association of prothrombin complex concentrate administration and hematoma enlargement in non-vitamin K antagonist oral anticoagulant-related intracerebral hemorrhage
- (2018) Stefan T. Gerner et al. ANNALS OF NEUROLOGY
- Telemonitoring-based feedback improves adherence to non-vitamin K antagonist oral anticoagulants intake in patients with atrial fibrillation
- (2018) Lien Desteghe et al. EUROPEAN HEART JOURNAL
- Rivaroxaban-induced hepatotoxicity
- (2018) Anna Licata et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Major bleeding and intracranial hemorrhage risk prediction in patients with atrial fibrillation: Attention to modifiable bleeding risk factors or use of a bleeding risk stratification score? A nationwide cohort study
- (2018) Tze-Fan Chao et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Association of Intracerebral Hemorrhage Among Patients Taking Non–Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality
- (2018) Taku Inohara et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Characteristics of Symptomatic Intracerebral Hemorrhage in Patient Receiving Direct Oral Anticoagulants: Comparison with Warfarin
- (2018) Masahito Kawabori et al. Journal of Stroke & Cerebrovascular Diseases
- Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation
- (2018) Tze-Fan Chao et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Prestroke Mobility and Dementia as Predictors of Stroke Outcomes in Patients Over 65 Years of Age: A Cohort Study From The Swedish Dementia and Stroke Registries
- (2018) Sara Garcia-Ptacek et al. Journal of the American Medical Directors Association
- Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial
- (2018) Olivier Varenne et al. LANCET
- Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
- (2018) Gary E. Raskob et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging
- (2018) Gregory W. Albers et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
- (2018) Raul G. Nogueira et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
- (2018) William J. Powers et al. STROKE
- Characteristics of Symptomatic Intracerebral Hemorrhage in Patient Receiving Direct Oral Anticoagulants: Comparison with Warfarin
- (2018) Masahito Kawabori et al. Journal of Stroke & Cerebrovascular Diseases
- P817Effect of individualised education sessions on the knowledge level of patients with atrial fibrillation
- (2017) L. Desteghe et al. EUROPACE
- Frailty syndrome: an emerging clinical problem in the everyday management of clinical arrhythmias. The results of the European Heart Rhythm Association survey
- (2017) Stefano Fumagalli et al. EUROPACE
- Does atrial fibrillation cause cognitive decline and dementia?
- (2017) Joanna Dietzel et al. EUROPACE
- Interruption of non-vitamin K antagonist anticoagulants in patients undergoing planned invasive procedures: how long is long enough?
- (2017) Johann Auer et al. EUROPEAN HEART JOURNAL
- Predictors of pre-procedural concentrations of direct oral anticoagulants: a prospective multicentre study
- (2017) Anne Godier et al. EUROPEAN HEART JOURNAL
- 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
- (2017) Borja Ibanez et al. EUROPEAN HEART JOURNAL
- Less dementia with oral anticoagulation in atrial fibrillation
- (2017) Leif Friberg et al. EUROPEAN HEART JOURNAL
- 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
- (2017) Marco Valgimigli et al. EUROPEAN HEART JOURNAL
- 2017 ESC/EACTS Guidelines for the management of valvular heart disease
- (2017) Helmut Baumgartner et al. EUROPEAN HEART JOURNAL
- The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis
- (2017) Justine Hum et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Drug-induced liver injury with oral anticoagulants: a threat or not?
- (2017) Tatjana S Potpara et al. HEART
- Prospective study of oral anticoagulants and risk of liver injury in patients with atrial fibrillation
- (2017) Alvaro Alonso et al. HEART
- Early non-persistence with dabigatran and rivaroxaban in patients with atrial fibrillation
- (2017) Cynthia A Jackevicius et al. HEART
- Real-world evidence with apixaban for stroke prevention in patients with nonvalvular atrial fibrillation in Germany: a retrospective study (REASSESS)
- (2017) Craig Ian Coleman et al. Internal and Emergency Medicine
- First experience with edoxaban and atrial fibrillation ablation – Insights from the ENGAGE AF-TIMI 48 trial
- (2017) Jan Steffel et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Body mass index is an independent predictor of major bleeding in non-valvular atrial fibrillation patients taking dabigatran
- (2017) Chen-Hung Lee et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation
- (2017) Fernando Dominguez et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Direct oral anti-coagulants compared with vitamin-K inhibitors and low-molecular-weight-heparin for the prevention of venous thromboembolism in patients with cancer: A meta-analysis study
- (2017) Natale Daniele Brunetti et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany – A national case collection
- (2017) Pawel Kermer et al. International Journal of Stroke
- Postapproval Observational Studies of Non–Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation
- (2017) Tatjana S. Potpara et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comparisons of Interventions for Preventing Falls in Older Adults
- (2017) Andrea C. Tricco et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Increased rates of atrial fibrillation recurrence following pulmonary vein isolation in overweight and obese patients
- (2017) Bhradeev Sivasambu et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary
- (2017) Hugh Calkins et al. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
- Intravenous thrombolysis and clot retrieval following reversal of dabigatran with idarucizumab
- (2017) Dominic MY Tse et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice
- (2017) Gargi Banerjee et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation
- (2017) Miney Paquette et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Obesity and Atrial Fibrillation Prevalence, Pathogenesis, and Prognosis
- (2017) Carl J. Lavie et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease
- (2017) Giulia Renda et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial
- (2017) Raffaele De Caterina et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants
- (2017) Gordon F. Tomaselli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Changing Landscape for Stroke Prevention in AF
- (2017) Menno V. Huisman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Non–Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction
- (2017) Xiaoxi Yao et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of New Oral Anticoagulants on Prescribing Practices for Atrial Fibrillation in Older Adults
- (2017) Raymond B. Fohtung et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Apixaban Pharmacokinetics at Steady State in Hemodialysis Patients
- (2017) Thomas A. Mavrakanas et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Dissociation between the pharmacokinetics and pharmacodynamics of once-daily rivaroxaban and twice-daily apixaban: a randomized crossover study
- (2017) R. Kreutz et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Reversal of apixaban anticoagulation by four-factor prothrombin complex concentrates in healthy subjects: a randomized three-period crossover study
- (2017) Y. Song et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians
- (2017) J. Douxfils et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial
- (2017) Dragos Vinereanu et al. LANCET
- The future of atrial fibrillation management: integrated care and stratified therapy
- (2017) Paulus Kirchhof LANCET
- Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation
- (2017) Eleni Korompoki et al. NEUROLOGY
- Outcome of intracerebral hemorrhage associated with different oral anticoagulants
- (2017) Duncan Wilson et al. NEUROLOGY
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
- (2017) John W. Eikelboom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Triple Therapy for Atrial Fibrillation after PCI
- (2017) Jonathan P. Piccini et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
- (2017) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Idarucizumab for Dabigatran Reversal — Full Cohort Analysis
- (2017) Charles V. Pollack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
- (2017) Jeffrey I. Weitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation
- (2017) Hugh Calkins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Real-World Adherence and Persistence with Direct Oral Anticoagulants in Adults with Atrial Fibrillation
- (2017) Beenish S. Manzoor et al. PHARMACOTHERAPY
- Interventional Spine and Pain Procedures in Patients on Antiplatelet and Anticoagulant Medications (Second Edition)
- (2017) Samer Narouze et al. REGIONAL ANESTHESIA AND PAIN MEDICINE
- Incidence of seizures following initial ischemic stroke in a community-based cohort: The Framingham Heart Study
- (2017) Maria Stefanidou et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Emergency Coagulation Assessment During Treatment With Direct Oral Anticoagulants
- (2017) Matthias Ebner et al. STROKE
- Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation
- (2017) George Ntaios et al. STROKE
- Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation
- (2017) Ying Bai et al. STROKE
- Using Artificial Intelligence to Reduce the Risk of Nonadherence in Patients on Anticoagulation Therapy
- (2017) Daniel L. Labovitz et al. STROKE
- The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale
- (2017) Alex Spyropoulos et al. THROMBOSIS AND HAEMOSTASIS
- Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in “real-world” clinical practice
- (2017) Steve Deitelzweig et al. THROMBOSIS AND HAEMOSTASIS
- Assessing Bleeding Risk in Atrial Fibrillation Patients: Comparing a Bleeding Risk Score Based Only on Modifiable Bleeding Risk Factors against the HAS-BLED Score. The AMADEUS Trial
- (2017) María Esteve-Pastor et al. THROMBOSIS AND HAEMOSTASIS
- Risks of postextraction bleeding after receiving direct oral anticoagulants or warfarin: a retrospective cohort study
- (2017) Takahiro Yagyuu et al. BMJ Open
- Effects of Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta‐Analysis
- (2017) Kuo‐Li Pan et al. Journal of the American Heart Association
- Early Recurrence and Major Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Treated With Non–Vitamin‐K Oral Anticoagulants (RAF‐NOACs) Study
- (2017) Maurizio Paciaroni et al. Journal of the American Heart Association
- Major Bleeding Complications and Persistence With Oral Anticoagulation in Non‐Valvular Atrial Fibrillation: Contemporary Findings in Real‐Life Danish Patients
- (2017) Morten Lamberts et al. Journal of the American Heart Association
- Thromboembolic and bleeding complications during oral anticoagulation therapy in cancer patients with atrial fibrillation: a Danish nationwide population-based cohort study
- (2017) Anne G. Ording et al. Cancer Medicine
- Drug interactions with new oral anticoagulants in elderly patients
- (2017) Claudia Stöllberger Expert Review of Clinical Pharmacology
- Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP) – September 2015
- (2017) Pierre Albaladejo et al. Anaesthesia Critical Care & Pain Medicine
- Intravenous Thrombolysis in Patients with Stroke Taking Rivaroxaban Using Drug Specific Plasma Levels: Experience with a Standard Operation Procedure in Clinical Practice
- (2017) David J. Seiffge et al. Journal of Stroke
- Major Bleeding Risk During Anticoagulation with Warfarin, Dabigatran, Apixaban, or Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation
- (2017) Gboyega Adeboyeje et al. Journal of Managed Care & Specialty Pharmacy
- Apixaban compared with parenteral heparin and/or vitamin K antagonist in patients with nonvalvular atrial fibrillation undergoing cardioversion: Rationale and design of the EMANATE trial
- (2016) Michael D. Ezekowitz et al. AMERICAN HEART JOURNAL
- A randomized trial to compare the safety of rivaroxaban vs aspirin in addition to either clopidogrel or ticagrelor in acute coronary syndrome: The design of the GEMINI-ACS-1 phase II study
- (2016) Thomas J. Povsic et al. AMERICAN HEART JOURNAL
- Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF)
- (2016) Gregory Y.H. Lip et al. AMERICAN HEART JOURNAL
- Ischemic and bleeding events in patients with myocardial infarction undergoing percutaneous coronary intervention who require oral anticoagulation: Insights from the Canadian observational AntiPlatelet sTudy
- (2016) Steven Sra et al. AMERICAN HEART JOURNAL
- Anticoagulation, CHA2DS2VASc Score, and Thromboembolic Risk of Cardioversion of Acute Atrial Fibrillation (from the FinCV Study)
- (2016) Toni Grönberg et al. AMERICAN JOURNAL OF CARDIOLOGY
- A Summary of the Literature Evaluating Adherence and Persistence with Oral Anticoagulants in Atrial Fibrillation
- (2016) Kehinde O. Obamiro et al. American Journal of Cardiovascular Drugs
- Effect of Rifampin on the Pharmacokinetics of Apixaban, an Oral Direct Inhibitor of Factor Xa
- (2016) Blisse Vakkalagadda et al. American Journal of Cardiovascular Drugs
- Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease
- (2016) Renato D. Lopes et al. AMERICAN JOURNAL OF MEDICINE
- Mortality in Patients with Atrial Fibrillation Randomized to Edoxaban or Warfarin: Insights from the ENGAGE AF-TIMI 48 Trial
- (2016) Robert P. Giugliano et al. AMERICAN JOURNAL OF MEDICINE
- Effective and safe proton pump inhibitor therapy in acid-related diseases – A position paper addressing benefits and potential harms of acid suppression
- (2016) Carmelo Scarpignato et al. BMC Medicine
- Edoxaban drug-drug interactions with ketoconazole, erythromycin, and cyclosporine
- (2016) Dolly A. Parasrampuria et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Nonvalvular Atrial Fibrillation
- (2016) Peter A. Noseworthy et al. CHEST
- On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With WarfarinClinical Perspective
- (2016) Christopher B. Fordyce et al. CIRCULATION
- Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 TrialClinical Perspective
- (2016) Erin A. Bohula et al. CIRCULATION
- Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart DiseaseClinical Perspective
- (2016) Michael D. Ezekowitz et al. CIRCULATION
- Cardio-Oncology
- (2016) Carrie G. Lenneman et al. CIRCULATION RESEARCH
- Special considerations for therapeutic choice of non-vitamin K antagonist oral anticoagulants for Japanese patients with nonvalvular atrial fibrillation
- (2016) Ken Okumura et al. CLINICAL CARDIOLOGY
- Sex Differences in the Association Between Regular Physical Activity and Incident Atrial Fibrillation: A Meta-analysis of 13 Prospective Studies
- (2016) Wen-Gen Zhu et al. CLINICAL CARDIOLOGY
- Pragmatic approach to manage new oral anticoagulants in patients undergoing dental extractions: a prospective case-control study
- (2016) Isabel Miclotte et al. Clinical Oral Investigations
- Comparison of Adherence to Rivaroxaban Versus Apixaban Among Patients With Atrial Fibrillation
- (2016) Colleen A. McHorney et al. CLINICAL THERAPEUTICS
- Evaluation of Crushed Tablet for Oral Administration and the Effect of Food on Apixaban Pharmacokinetics in Healthy Adults
- (2016) Yan Song et al. CLINICAL THERAPEUTICS
- Idarucizumab for dabigatran overdose
- (2016) Marijke Peetermans et al. CLINICAL TOXICOLOGY
- Evaluation of SAMe-TT2R2score and other clinical factors influencing the quality of anticoagulation therapy in non-valvular atrial fibrillation: a nationwide study in Spain
- (2016) José M. Lobos-Bejarano et al. CURRENT MEDICAL RESEARCH AND OPINION
- The safety and persistence of non-vitamin-K-antagonist oral anticoagulants in atrial fibrillation patients treated in a well structured atrial fibrillation clinic
- (2016) Faris Al-Khalili et al. CURRENT MEDICAL RESEARCH AND OPINION
- The Complex Role of Anticoagulation in Cirrhosis: An Updated Review of Where We Are and Where We Are Going
- (2016) Tawfik Khoury et al. DIGESTION
- Direct Oral Anticoagulants in Cirrhosis Patients Pose Similar Risks of Bleeding When Compared to Traditional Anticoagulation
- (2016) N. M. Intagliata et al. DIGESTIVE DISEASES AND SCIENCES
- Interactions between non-vitamin K oral anticoagulants and antiepileptic drugs
- (2016) Claudia Stöllberger et al. EPILEPSY RESEARCH
- Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation
- (2016) Luigi Di Biase et al. EUROPACE
- Real-world persistence and adherence to oral anticoagulation for stroke risk reduction in patients with atrial fibrillation
- (2016) Jan Beyer-Westendorf et al. EUROPACE
- The ‘obesity paradox’ in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial
- (2016) Roopinder K. Sandhu et al. EUROPEAN HEART JOURNAL
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
- (2016) Jose Luis Zamorano et al. EUROPEAN HEART JOURNAL
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
- (2016) Paulus Kirchhof et al. EUROPEAN HEART JOURNAL
- Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: insights from ENGAGE AF-TIMI 48
- (2016) Giulia Magnani et al. EUROPEAN JOURNAL OF HEART FAILURE
- Association of Proton Pump Inhibitors With Reduced Risk of Warfarin-Related Serious Upper Gastrointestinal Bleeding
- (2016) Wayne A. Ray et al. GASTROENTEROLOGY
- Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation
- (2016) A John Camm et al. HEART
- Medication adherence to rivaroxaban and dabigatran for stroke prevention in patients with non-valvular atrial fibrillation in the United States
- (2016) Craig I. Coleman et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Knowledge gaps in patients with atrial fibrillation revealed by a new validated knowledge questionnaire
- (2016) Lien Desteghe et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Association between once- and twice-daily direct oral anticoagulant adherence in nonvalvular atrial fibrillation patients and rates of ischemic stroke
- (2016) Mark J. Alberts et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and valvular heart disease
- (2016) Peter A. Noseworthy et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Impact of once- or twice-daily dosing frequency on adherence to chronic cardiovascular disease medications: A meta-regression analysis
- (2016) Erin R. Weeda et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The Importance of Patient-Specific Factors for Hepatic Drug Response and Toxicity
- (2016) Volker Lauschke et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- An evidence summary of the management of patients taking direct oral anticoagulants (DOACs) undergoing dental surgery
- (2016) S. Johnston INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- Measuring non-vitamin K antagonist oral anticoagulant levels: When is it appropriate and which methods should be used?
- (2016) Ludovic Drouet et al. International Journal of Stroke
- Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis
- (2016) Jeffrey L. Saver et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Meta-analysis of efficacy and safety of apixaban and uninterrupted apixaban therapy compared to vitamin K antagonists in patients undergoing catheter ablation for atrial fibrillation
- (2016) Anene Ukaigwe et al. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
- Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation
- (2016) Peter A. Noseworthy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling
- (2016) Jan Steffel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Obesity and risk of bleeding: the SMART study.
- (2016) S. K. Braekkan et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- To measure or not to measure direct oral anticoagulants before surgery or invasive procedures: reply
- (2016) A. Tripodi JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Bleeding risk assessment in atrial fibrillation: observations on the use and misuse of bleeding risk scores
- (2016) G. Y. H. Lip et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH
- (2016) J. H. Levy et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH
- (2016) K. Martin et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment
- (2016) Allison E. Burnett et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial
- (2016) Andreas Goette et al. LANCET
- The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study
- (2016) Ziad Hijazi et al. LANCET
- Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
- (2016) C. Michael Gibson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors
- (2016) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reduced Anticoagulant Effect of Dabigatran in a Patient Receiving Concomitant Phenytoin
- (2016) Barbara S. Wiggins et al. PHARMACOTHERAPY
- Safety of Endovascular Thrombectomy in Patients Receiving Non–Vitamin K Antagonist Oral Anticoagulants
- (2016) Jan C. Purrucker et al. STROKE
- Coagulation Testing in Acute Ischemic Stroke Patients Taking Non–Vitamin K Antagonist Oral Anticoagulants
- (2016) Jan C. Purrucker et al. STROKE
- Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC
- (2016) Anja Katholing et al. THROMBOSIS AND HAEMOSTASIS
- Rivaroxaban real-world evidence: Validating safety and effectiveness in clinical practice
- (2016) A. Camm et al. THROMBOSIS AND HAEMOSTASIS
- Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin
- (2016) Allison Keshishian et al. THROMBOSIS AND HAEMOSTASIS
- Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial
- (2016) Jeroen Jaspers Focks et al. BMJ-British Medical Journal
- Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
- (2016) Torben Bjerregaard Larsen et al. BMJ-British Medical Journal
- Management of dental extraction in patients undergoing anticoagulant oral direct treatment: a pilot study
- (2016) Cédric Mauprivez et al. Oral Surgery Oral Medicine Oral Pathology Oral Radiology
- Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial
- (2016) Jeroen Jaspers Focks et al. BMJ-British Medical Journal
- Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
- (2016) Torben Bjerregaard Larsen et al. BMJ-British Medical Journal
- Increased Peripheral Arterial Calcification in Patients Receiving Warfarin
- (2016) Kum Hyun Han et al. Journal of the American Heart Association
- An Integrated Management Approach to Atrial Fibrillation
- (2016) Lindsey Carter et al. Journal of the American Heart Association
- Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 Trial
- (2016) Eri Toda Kato et al. Journal of the American Heart Association
- Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation
- (2016) Xiaoxi Yao et al. Journal of the American Heart Association
- Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF‐TIMI48 Trial
- (2016) Haiyan Xu et al. Journal of the American Heart Association
- Management and outcomes of vaginal bleeding and heavy menstrual bleeding in women of reproductive age on direct oral anti-factor Xa inhibitor therapy: a case series
- (2016) Jan Beyer-Westendorf et al. Lancet Haematology
- Mobile Phone Apps to Improve Medication Adherence: A Systematic Stepwise Process to Identify High-Quality Apps
- (2016) Karla Santo et al. JMIR mHealth and uHealth
- Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Nonvalvular Atrial Fibrillation
- (2016) Joshua D. Brown et al. Journal of Managed Care & Specialty Pharmacy
- Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine
- (2016) John H. Alexander et al. JAMA Cardiology
- Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in Relation to Renal Function Over Time
- (2016) Ziad Hijazi et al. JAMA Cardiology
- Impact of advanced age on management and prognosis in atrial fibrillation: insights from a population-based study in general practice
- (2015) Andreas Wolff et al. AGE AND AGEING
- Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
- (2015) Christopher B. Granger et al. AMERICAN HEART JOURNAL
- An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin k antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI)
- (2015) C. Michael Gibson et al. AMERICAN HEART JOURNAL
- Comparison of Safety of Left Atrial Catheter Ablation Procedures for Atrial Arrhythmias Under Continuous Anticoagulation With Apixaban Versus Phenprocoumon
- (2015) Bernhard M. Kaess et al. AMERICAN JOURNAL OF CARDIOLOGY
- Dose-Finding Study of Rivaroxaban in Hemodialysis Patients
- (2015) An S. De Vriese et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective ‘Real-world’ Inception Cohort Study
- (2015) Vanessa Roldán et al. AMERICAN JOURNAL OF MEDICINE
- Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use
- (2015) I. Martinelli et al. BLOOD
- Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor
- (2015) Charles E. Frost et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Intracranial Hemorrhage and Subsequent Ischemic Stroke in Patients With Atrial Fibrillation
- (2015) Peter Brønnum Nielsen et al. CHEST
- Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart DiseaseCLINICAL PERSPECTIVE
- (2015) Alvaro Avezum et al. CIRCULATION
- Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial FibrillationCLINICAL PERSPECTIVE
- (2015) Jonathan P. Piccini et al. CIRCULATION
- Patient Guide for Taking the Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation
- (2015) D. A. Lane et al. CIRCULATION
- Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis
- (2015) K. E. Chan et al. CIRCULATION
- Short-Term Safety and Plasma Concentrations of Edoxaban in Japanese Patients With Non-Valvular Atrial Fibrillation and Severe Renal Impairment
- (2015) Yukihiro Koretsune et al. CIRCULATION JOURNAL
- Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial
- (2015) Marco Proietti et al. Clinical Research in Cardiology
- Relative Bioavailability of Apixaban Solution or Crushed Tablet Formulations Administered by Mouth or Nasogastric Tube in Healthy Subjects
- (2015) Yan Song et al. CLINICAL THERAPEUTICS
- Pharmacy quality alliance measure: adherence to non-warfarin oral anticoagulant medications
- (2015) Concetta Crivera et al. CURRENT MEDICAL RESEARCH AND OPINION
- Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measure
- (2015) Colleen A. McHorney et al. CURRENT MEDICAL RESEARCH AND OPINION
- Anticoagulation reversal in the era of the non-vitamin K oral anticoagulants
- (2015) Andres Enriquez et al. EUROPACE
- Evaluation of SAMe-TT2R2 risk score for predicting the quality of anticoagulation control in a real-world cohort of patients with non-valvular atrial fibrillation on vitamin-K antagonists
- (2015) R. R.-Y. Abumuaileq et al. EUROPACE
- Drug persistence with rivaroxaban therapy in atrial fibrillation patients--results from the Dresden non-interventional oral anticoagulation registry
- (2015) J. Beyer-Westendorf et al. EUROPACE
- Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)
- (2015) Deirdre A. Lane et al. EUROPACE
- Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS)
- (2015) Christian Sticherling et al. EUROPACE
- Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation
- (2015) Hein Heidbuchel et al. EUROPACE
- Non-vitamin K antagonist oral anticoagulants: considerations on once- vs. twice-daily regimens and their potential impact on medication adherence
- (2015) B. Vrijens et al. EUROPACE
- Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial
- (2015) J. Steffel et al. EUROPEAN HEART JOURNAL
- Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation
- (2015) Riccardo Cappato et al. EUROPEAN HEART JOURNAL
- 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
- (2015) Marco Roffi et al. EUROPEAN HEART JOURNAL
- Comparison of treatment persistence with different oral anticoagulants in patients with atrial fibrillation
- (2015) Tomas Forslund et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Prevention of Dabigatran-Related Gastrointestinal Bleeding With Gastroprotective Agents: A Population-Based Study
- (2015) Esther W. Chan et al. GASTROENTEROLOGY
- Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: Results from a multicenter study
- (2015) Luigi Di Biase et al. HEART RHYTHM
- Mechanical thrombectomy in acute ischemic stroke: Consensus statement by ESO-Karolinska Stroke Update 2014/2015, supported by ESO, ESMINT, ESNR and EAN
- (2015) Nils Wahlgren et al. International Journal of Stroke
- Anticoagulant Reversal, Blood Pressure Levels, and Anticoagulant Resumption in Patients With Anticoagulation-Related Intracerebral Hemorrhage
- (2015) Joji B. Kuramatsu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Site-Level Variation in and Practices Associated With Dabigatran Adherence
- (2015) Supriya Shore et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis
- (2015) Xiaoli Wang et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation
- (2015) A. M. Shields et al. JOURNAL OF INTERNAL MEDICINE
- Changes in Renal Function in Patients With Atrial Fibrillation
- (2015) Michael Böhm et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH
- (2015) G. D. Barnes et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study
- (2015) A. Gorst-Rasmussen et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Laboratory measurement of the anticoagulant activity of edoxaban: a systematic review
- (2015) Adam Cuker et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial
- (2015) Christian T Ruff et al. LANCET
- Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial
- (2015) Marco Valgimigli et al. LANCET
- Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
- (2015) James D. Douketis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk
- (2015) Philip Urban et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
- (2015) Marc P. Bonaca et al. NEW ENGLAND JOURNAL OF MEDICINE
- Managing dentoalveolar surgical procedures in patients taking new oral anticoagulants
- (2015) Stefano Sivolella et al. Odontology
- Interventional Spine and Pain Procedures in Patients on Antiplatelet and Anticoagulant Medications
- (2015) Samer Narouze et al. REGIONAL ANESTHESIA AND PAIN MEDICINE
- Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation
- (2015) Maurizio Paciaroni et al. STROKE
- Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
- (2015) J. Claude Hemphill et al. STROKE
- Validation of the SAMe-TT2R2 score in a nationwide population of nonvalvular atrial fibrillation patients on vitamin K antagonists
- (2015) Vicente Bertomeu et al. THROMBOSIS AND HAEMOSTASIS
- Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis
- (2015) Thomas Marbury et al. THROMBOSIS AND HAEMOSTASIS
- Peri-procedural use of rivaroxaban in elective percutaneous coronary intervention to treat stable coronary artery disease
- (2015) Pascal Vranckx et al. THROMBOSIS AND HAEMOSTASIS
- Genotype-guided versus standard vitamin K antagonist dosing algorithms in patients initiating anticoagulation
- (2015) Emilie Belley-Cote et al. THROMBOSIS AND HAEMOSTASIS
- Comparison of dosing algorithms for acenocoumarol and phenprocoumon using clinical factors with the standard care in the Netherlands
- (2015) Yumao Zhang et al. THROMBOSIS RESEARCH
- Treatment of venous thromboembolism in patients with cancer: A network meta-analysis comparing efficacy and safety of anticoagulants
- (2015) Florian Posch et al. THROMBOSIS RESEARCH
- Gastrointestinal bleeding in patients receiving oral anticoagulation: Current treatment and pharmacological perspectives
- (2015) Alessandro Di Minno et al. THROMBOSIS RESEARCH
- Abnormal uterine bleeding in VTE patients treated with rivaroxaban compared to vitamin K antagonists
- (2015) Nico De Crem et al. THROMBOSIS RESEARCH
- Adherence to a Novel Oral Anticoagulant Among Patients with Atrial Fibrillation
- (2015) Meijia Zhou et al. Journal of Managed Care & Specialty Pharmacy
- Adherence to dabigatran therapy and longitudinal patient outcomes: Insights from the Veterans Health Administration
- (2014) Supriya Shore et al. AMERICAN HEART JOURNAL
- Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry
- (2014) J. Beyer-Westendorf et al. BLOOD
- Evaluation of the effect of naproxen on the pharmacokinetics and pharmacodynamics of apixaban
- (2014) Charles Frost et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Intermittent haemodialysis and continuous veno-venous dialysis are effective in mitigating major bleeding due to dabigatran
- (2014) Bartlomiej Getta et al. BRITISH JOURNAL OF HAEMATOLOGY
- Warfarin Use and the Risk for Stroke and Bleeding in Patients With Atrial Fibrillation Undergoing Dialysis
- (2014) Mitesh Shah et al. CIRCULATION
- Periprocedural Stroke and Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation With Different Anticoagulation Management
- (2014) Luigi Di Biase et al. CIRCULATION
- Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)
- (2014) Jonathan L. Halperin et al. CIRCULATION
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2014) Craig T. January et al. CIRCULATION
- Stratifying the Risks of Oral Anticoagulation in Patients With Liver Disease
- (2014) Lydia M. Efird et al.
- Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients
- (2014) François Laliberté et al. CURRENT MEDICAL RESEARCH AND OPINION
- Medication persistence and discontinuation of rivaroxaban versus warfarin among patients with non-valvular atrial fibrillation
- (2014) Winnie W. Nelson et al. CURRENT MEDICAL RESEARCH AND OPINION
- Best Practice for Atrial Fibrillation Patient Education
- (2014) Deirdre Lane et al. CURRENT PHARMACEUTICAL DESIGN
- Thromboembolic risk in 16 274 atrial fibrillation patients undergoing direct current cardioversion with and without oral anticoagulant therapy
- (2014) Morten Lock Hansen et al. EUROPACE
- Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial
- (2014) S. Halvorsen et al. EUROPEAN HEART JOURNAL
- Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation
- (2014) Riccardo Cappato et al. EUROPEAN HEART JOURNAL
- Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial
- (2014) J. P. Piccini et al. EUROPEAN HEART JOURNAL
- Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial
- (2014) Günter Breithardt et al. EUROPEAN HEART JOURNAL
- Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study
- (2014) Leif Friberg et al. EUROPEAN HEART JOURNAL
- Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry
- (2014) J. Beyer-Westendorf et al. EUROPEAN HEART JOURNAL
- 2014 ESC/EACTS Guidelines on myocardial revascularization
- (2014) EUROPEAN HEART JOURNAL
- Edoxaban population pharmacokinetics and exposure–response analysis in patients with non-valvular atrial fibrillation
- (2014) Ophelia Q. P. Yin et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Risk of drug-induced liver injury with the new oral anticoagulants: systematic review and meta-analysis
- (2014) Daniel Caldeira et al. HEART
- Prolonged anticoagulant activity of rivaroxaban in a polymorbid elderly female with non-convulsive epileptic state
- (2014) Claudia Stöllberger et al. HEART & LUNG
- Physical activity and incidence of atrial fibrillation: A systematic review and meta-analysis
- (2014) Chun Shing Kwok et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Time to Cardioversion for Acute Atrial Fibrillation and Thromboembolic Complications
- (2014) Ilpo Nuotio et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Transition of Patients From Blinded Study Drug to Open-Label Anticoagulation
- (2014) Christian T. Ruff et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Net Clinical Benefit of Antithrombotic Therapy in Patients With Atrial Fibrillation and Chronic Kidney Disease
- (2014) Anders Nissen Bonde et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin
- (2014) Elaine M. Hylek et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Rivaroxaban presents a better pharmacokinetic profile than dabigatran in an obese non-diabetic stroke patient
- (2014) Apostolos Safouris et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Comparison of three-factor and four-factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers
- (2014) M. Levi et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
- (2014) Laura Mauri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of PER977 to Reverse the Anticoagulant Effect of Edoxaban
- (2014) Jack E. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Point-of-Care Coagulation Testing for Assessment of the Pharmacodynamic Anticoagulant Effect of Direct Oral Anticoagulant
- (2014) Helen Mani et al. THERAPEUTIC DRUG MONITORING
- Safety and Efficacy of Edoxaban, an Oral Factor Xa Inhibitor, Versus Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty: The STARS E-3 Trial
- (2014) Takeshi Fuji et al. THROMBOSIS RESEARCH
- Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety
- (2014) J. Poeran et al. BMJ-British Medical Journal
- Genotype-Guided vs Clinical Dosing of Warfarin and Its Analogues
- (2014) Kathleen Stergiopoulos et al. JAMA Internal Medicine
- Intracranial Hemorrhage and Novel Anticoagulants for Atrial Fibrillation: What Have We Learned?
- (2014) Graeme J. Hankey Current Cardiology Reports
- Drug-Drug Interaction Studies of Cardiovascular Drugs Involving P-Glycoprotein, an Efflux Transporter, on the Pharmacokinetics of Edoxaban, an Oral Factor Xa Inhibitor
- (2013) Jeanne Mendell et al. American Journal of Cardiovascular Drugs
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- Expert consensus of the French Society of Geriatrics and Gerontology and the French Society of Cardiology on the management of atrial fibrillation in elderly people
- (2013) Olivier Hanon et al. Archives of Cardiovascular Diseases
- Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects
- (2013) Vijay V. Upreti et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitor
- (2013) Dagmar Kubitza et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Co-administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects
- (2013) Wolfgang Mueck et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Factors Affecting Quality of Anticoagulation Control Among Patients With Atrial Fibrillation on Warfarin
- (2013) Stavros Apostolakis et al. CHEST
- Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin
- (2013) Ammar Majeed et al. CIRCULATION
- Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation
- (2013) Ziad Hijazi et al. CIRCULATION
- Use of Dabigatran for Periprocedural Anticoagulation in Patients Undergoing Catheter Ablation for Atrial Fibrillation
- (2013) Mohamed Bassiouny et al. Circulation-Arrhythmia and Electrophysiology
- Higher Persistence in Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran Versus Warfarin
- (2013) Martin Zalesak et al.
- Efficacy and Safety of Rivaroxaban in Patients With Heart Failure and Nonvalvular Atrial Fibrillation
- (2013) Sean van Diepen et al. Circulation-Heart Failure
- Left Ventricular Systolic Dysfunction, Heart Failure, and the Risk of Stroke and Systemic Embolism in Patients With Atrial Fibrillation
- (2013) John J.V. McMurray et al. Circulation-Heart Failure
- Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban
- (2013) Wolfgang Mueck et al. CLINICAL PHARMACOKINETICS
- European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation
- (2013) Hein Heidbuchel et al. EUROPACE
- Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial
- (2013) J. H. Alexander et al. EUROPEAN HEART JOURNAL
- A proposal for interdisciplinary, nurse-coordinated atrial fibrillation expert programmes as a way to structure daily practice
- (2013) Dana Berti et al. EUROPEAN HEART JOURNAL
- New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis
- (2013) J. Oldgren et al. EUROPEAN HEART JOURNAL
- Effect of Weight Reduction and Cardiometabolic Risk Factor Management on Symptom Burden and Severity in Patients With Atrial Fibrillation
- (2013) Hany S. Abed et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Outcomes After Cardioversion and Atrial Fibrillation Ablation in Patients Treated With Rivaroxaban and Warfarin in the ROCKET AF Trial
- (2013) Jonathan P. Piccini et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy and Safety of Dabigatran Etexilate and Warfarin in “Real-World” Patients With Atrial Fibrillation
- (2013) Torben Bjerregaard Larsen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Outcomes of Discontinuing Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation
- (2013) Manesh R. Patel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation
- (2013) Greg Flaker et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients
- (2013) Paul A. Reilly et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Insights Into Onco-Cardiology
- (2013) Dimitrios Farmakis et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial
- (2013) Willem JM Dewilde et al. LANCET
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
- (2013) Christian T Ruff et al. LANCET
- Ischemic Stroke in an Obese Patient Receiving Dabigatran
- (2013) Lorenz Breuer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation
- (2013) David H. Birnie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism
- (2013) Sam Schulman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Apixaban for the Treatment of Acute Venous Thromboembolism
- (2013) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- New Oral Anticoagulants and the Cancer Patient
- (2013) N. J. Short et al. ONCOLOGIST
- Preventing Stroke in Patients With Chronic Kidney Disease and Atrial Fibrillation
- (2013) Holger Reinecke et al. STROKE
- Impact of apixaban on routine and specific coagulation assays: a practical laboratory guide
- (2013) Christian Chatelain et al. THROMBOSIS AND HAEMOSTASIS
- Patient outcomes using the European label for dabigatran
- (2013) Andreas Clemens et al. THROMBOSIS AND HAEMOSTASIS
- A randomised study of dabigatran in elective percutaneous coronary intervention in stable coronary artery disease patients
- (2013) Pascal Vranckx et al. EuroIntervention
- Impact of Daily Dosing Frequency on Adherence to Chronic Medications Among Nonvalvular Atrial Fibrillation Patients
- (2012) François Laliberté et al. ADVANCES IN THERAPY
- Interpretation of Point-of-care INR Results in Patients Treated with Dabigatran
- (2012) Joanne van Ryn et al. AMERICAN JOURNAL OF MEDICINE
- Atrial Fibrillation and Acute Myocardial Infarction: Antithrombotic Therapy and Outcomes
- (2012) Renato D. Lopes et al. AMERICAN JOURNAL OF MEDICINE
- Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding
- (2012) T. E. Warkentin et al. BLOOD
- Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention
- (2012) Morten Lamberts et al. CIRCULATION
- Myocardial Ischemic Events in Patients With Atrial Fibrillation Treated With Dabigatran or Warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial
- (2012) Stefan H. Hohnloser et al. CIRCULATION
- Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin
- (2012) Jeff S. Healey et al. CIRCULATION
- Variation in Warfarin Dose Adjustment Practice Is Responsible for Differences in the Quality of Anticoagulation Control Between Centers and Countries
- (2012) Harriette G.C. Van Spall et al. CIRCULATION
- Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial
- (2012) Antonio L. Dans et al. CIRCULATION
- Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation
- (2012) Masatsugu Hori et al. CIRCULATION JOURNAL
- A clinical decision aid for the selection of antithrombotic therapy for the prevention of stroke due to atrial fibrillation
- (2012) Stephen Andrew LaHaye et al. EUROPEAN HEART JOURNAL
- Apixaban in renal insufficiency: successful navigation between the Scylla and Charybdis
- (2012) J. Steffel et al. EUROPEAN HEART JOURNAL
- Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial
- (2012) Stefan H. Hohnloser et al. EUROPEAN HEART JOURNAL
- Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation
- (2012) J. M. L. Hendriks et al. EUROPEAN HEART JOURNAL
- Incident thromboembolism and heart failure associated with new-onset atrial fibrillation in cancer patients
- (2012) Yu-feng Hu et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Reversal of dabigatran anticoagulation by prothrombin complex concentrate (Beriplex P/N) in a rabbit model
- (2012) I. PRAGST et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Comparison of initial warfarin response in obese patients versus non-obese patients
- (2012) Jessica L. Wallace et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease
- (2012) Jonas Bjerring Olesen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban for Extended Treatment of Venous Thromboembolism
- (2012) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of dabigatran on a large panel of routine or specific coagulation assays
- (2012) Séverine Robert et al. THROMBOSIS AND HAEMOSTASIS
- Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: Resolving uncertainties in routine practice
- (2012) Gregory Y. H. Lip et al. THROMBOSIS AND HAEMOSTASIS
- Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillation
- (2012) Jeanne Mendell et al. THROMBOSIS AND HAEMOSTASIS
- Assessment of the impact of rivaroxaban on coagulation assays: Laboratory recommendations for the monitoring of rivaroxaban and review of the literature
- (2012) Jonathan Douxfils et al. THROMBOSIS RESEARCH
- Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-Analysis
- (2012) Freesia Horsted et al. PLOS MEDICINE
- The transport of antiepileptic drugs by P-glycoprotein
- (2011) Chunbo Zhang et al. ADVANCED DRUG DELIVERY REVIEWS
- Evaluation of Prothrombin Complex Concentrate and Recombinant Activated Factor VII to Reverse Rivaroxaban in a Rabbit Model
- (2011) Anne Godier et al. ANESTHESIOLOGY
- Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
- (2011) John W. Eikelboom et al. CIRCULATION
- Dabigatran Versus Warfarin in Patients With Atrial Fibrillation
- (2011) Rangadham Nagarakanti et al. CIRCULATION
- Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate
- (2011) Elise S. Eerenberg et al. CIRCULATION
- Warfarin in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease
- (2011) R. G. Hart et al. Clinical Journal of the American Society of Nephrology
- Rivaroxaban
- (2011) Wolfgang Mueck et al. CLINICAL PHARMACOKINETICS
- Menstrual problems and contraception in women of reproductive age receiving oral anticoagulation
- (2011) Farah Yasmine Huq et al. CONTRACEPTION
- Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment
- (2011) K. A. A. Fox et al. EUROPEAN HEART JOURNAL
- Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data
- (2011) Rianne M.F. van Schie et al. EUROPEAN HEART JOURNAL
- In Vitro and In Vivo P-Glycoprotein Transport Characteristics of Rivaroxaban
- (2011) M. J. Gnoth et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial
- (2011) K.-H. LIESENFELD et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents
- (2011) M. LEVI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate
- (2011) Sergey V. Brodsky et al. KIDNEY INTERNATIONAL
- Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)
- (2011) Charles A. Herzog et al. KIDNEY INTERNATIONAL
- A case-control study of calciphylaxis in Japanese end-stage renal disease patients
- (2011) M. Hayashi et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Incidence and predictors of acute symptomatic seizures after stroke
- (2011) E. Beghi et al. NEUROLOGY
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
- (2011) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exposure to CYP3A4-inducing and CYP3A4-non-inducing antiepileptic agents and the risk of fractures
- (2011) Hedi Schelleman et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Hemostatic Therapy in Experimental Intracerebral Hemorrhage Associated With the Direct Thrombin Inhibitor Dabigatran
- (2011) Wei Zhou et al. STROKE
- Left Atrial Catheter Ablation and Ischemic Stroke
- (2011) Karl Georg Haeusler et al. STROKE
- Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II)
- (2011) Ola Dahl et al. THROMBOSIS AND HAEMOSTASIS
- Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)
- (2010) Christian T. Ruff et al. AMERICAN HEART JOURNAL
- Chronic kidney disease and prevalent atrial fibrillation: The Chronic Renal Insufficiency Cohort (CRIC)
- (2010) Elsayed Z. Soliman et al. AMERICAN HEART JOURNAL
- Risk Factors for Atrial Fibrillation After Lung Cancer Surgery: Analysis of The Society of Thoracic Surgeons General Thoracic Surgery Database
- (2010) Mark Onaitis et al. ANNALS OF THORACIC SURGERY
- Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate
- (2010) Joachim Stangier et al. CLINICAL PHARMACOKINETICS
- Incidence of left atrial thrombus prior to atrial fibrillation ablation: is pre-procedural transoesophageal echocardiography mandatory?
- (2010) J. W. McCready et al. EUROPACE
- Clinical Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Factor Xa Inhibitor Edoxaban in Healthy Volunteers
- (2010) Koichiro Ogata et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of Food on the Pharmacokinetics of Edoxaban, an Oral Direct Factor Xa Inhibitor, in Healthy Volunteers
- (2010) Jeanne Mendell et al. JOURNAL OF CLINICAL PHARMACOLOGY
- The Development and Validation of a Brief Performance-Based Fall Risk Assessment Tool for Use in Primary Care
- (2010) A. Tiedemann et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial
- (2010) Lars Wallentin et al. LANCET
- Oral Rivaroxaban for Symptomatic Venous Thromboembolism
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Assays for Measuring Rivaroxaban: Their Suitability and Limitations
- (2010) Edelgard Lindhoff-Last et al. THERAPEUTIC DRUG MONITORING
- Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
- (2010) Joachim Stangier et al. THROMBOSIS AND HAEMOSTASIS
- Apixaban versus enoxaparin in patients with total knee arthroplasty
- (2010) Jiahao Huang et al. THROMBOSIS AND HAEMOSTASIS
- A Frailty Instrument for primary care: findings from the Survey of Health, Ageing and Retirement in Europe (SHARE)
- (2010) Roman Romero-Ortuno et al. BMC Geriatrics
- Close bidirectional relationship between chronic kidney disease and atrial fibrillation: The Niigata preventive medicine study
- (2009) Hiroshi Watanabe et al. AMERICAN HEART JOURNAL
- Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome
- (2009) CIRCULATION
- Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation
- (2009) Alan S. Go et al. CIRCULATION
- Pharmacokinetics and Pharmacodynamics of the Direct Oral Thrombin Inhibitor Dabigatran in Healthy Elderly Subjects
- (2009) Joachim Stangier et al. CLINICAL PHARMACOKINETICS
- In Vitro Assessment of Metabolic Drug-Drug Interaction Potential of Apixaban through Cytochrome P450 Phenotyping, Inhibition, and Induction Studies
- (2009) L. Wang et al. DRUG METABOLISM AND DISPOSITION
- Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure
- (2009) Dale C. Hesdorffer et al. EPILEPSIA
- Introducing a new entity: chemotherapy-induced arrhythmia
- (2009) M. Guglin et al. EUROPACE
- Role of the CHADS2Score in the Evaluation of Thromboembolic Risk in Patients With Atrial Fibrillation Undergoing Transesophageal Echocardiography Before Pulmonary Vein Isolation
- (2009) Sarinya Puwanant et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial
- (2009) Alexander GG Turpie et al. LANCET
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
- (2009) Sam Schulman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme
- (2008) Stephan Rietbrock et al. AMERICAN HEART JOURNAL
- Dose-escalation study of the pharmacokinetics and pharmacodynamics of rivaroxaban in healthy elderly subjects
- (2008) Dagmar Kubitza et al. CURRENT MEDICAL RESEARCH AND OPINION
- Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans
- (2008) N. Raghavan et al. DRUG METABOLISM AND DISPOSITION
- Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment
- (2008) P. P. Karjalainen et al. EUROPEAN HEART JOURNAL
- Incidence and Predictors of Left Atrial Thrombus Prior to Catheter Ablation of Atrial Fibrillation
- (2008) DANIEL SCHERR et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- Effective Exercise for the Prevention of Falls: A Systematic Review and Meta-Analysis
- (2008) Catherine Sherrington et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Dilemmas in the Management of Atrial Fibrillation in Chronic Kidney Disease
- (2008) H. Reinecke et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial
- (2008) Ajay K Kakkar et al. LANCET
- Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
- (2008) Bengt I. Eriksson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty
- (2008) Michael R. Lassen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Calciphylaxis: Emerging Concepts in Prevention, Diagnosis, and Treatment
- (2003) William A Wilmer et al. SEMINARS IN DIALYSIS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now